1366482-40-7 Usage
Uses
Used in Pharmaceutical Synthesis:
2,3-Difluoropyridine-5-boronic acid is utilized as a key building block in the development of pharmaceuticals. Its unique structure allows for the creation of new drug candidates with improved pharmacological properties, including enhanced bioavailability and target specificity.
Used in Agrochemical Development:
In the agrochemical industry, 2,3-Difluoropyridine-5-boronic acid serves as a crucial component in the synthesis of new agrochemicals. Its reactivity and stability contribute to the development of more effective and environmentally friendly pesticides and other agricultural chemicals.
Used in Fine Chemicals Production:
2,3-Difluoropyridine-5-boronic acid is employed as a versatile building block in the synthesis of fine chemicals. Its ability to participate in a wide range of reactions makes it an indispensable tool for chemists in the creation of specialty chemicals used in various industries, such as fragrances, dyes, and advanced materials.
Used in Organic Synthesis Research:
As a reagent in organic synthesis, 2,3-Difluoropyridine-5-boronic acid is used for exploring novel reaction pathways and developing innovative synthetic methods. Its compatibility with diverse reaction conditions and its role in coupling and cross-coupling reactions make it a valuable asset for researchers in advancing the field of organic chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 1366482-40-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,6,6,4,8 and 2 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1366482-40:
(9*1)+(8*3)+(7*6)+(6*6)+(5*4)+(4*8)+(3*2)+(2*4)+(1*0)=177
177 % 10 = 7
So 1366482-40-7 is a valid CAS Registry Number.
1366482-40-7Relevant academic research and scientific papers
SUBSTITUTED IMIDAZO [1, 2-A] PYRIDINE AND [1, 2, 4] TRIAZOLO [1, 5-A] PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS
-
Paragraph 152-153; 229-231, (2020/05/12)
Provided are certain RET inhibitors, pharmaceutical compositions thereof, and methods of use thereof.
